The impact of catheter ablation for atrial fibrillation in heart failure

Atrial fibrillation (AF) commonly co‐exists with systolic heart failure (SHF) and its presence is associated with a worse prognosis. Despite this, a rhythm control approach using antiarrhythmic drugs (AADs) to reduce AF burden has demonstrated no prognostic benefit. Catheter ablation (AFA) is more e...

Full description

Saved in:
Bibliographic Details
Published in:Journal of arrhythmia 2019-02, Vol.35 (1), p.33-42
Main Authors: Moschonas, Konstantinos, Nabeebaccus, Adam, Okonko, Darlington O., McDonagh, Theresa A., Murgatroyd, Francis D., Dhillon, Para, Scott, Paul A.
Format: Article
Language:English
Subjects:
Ablation (Surgery)
Anti-arrhythmia drugs
Atrial fibrillation
Bias
Cardiac arrhythmia
catheter ablation
Catheters
Clinical medicine
Clinical Review
Clinical Reviews
Collaboration
Health aspects
Heart
Heart failure
Maximum oxygen consumption
Meta-analysis
Mortality
Prognosis
pulmonary vein isolation
Quality of life
Statistical analysis
Studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Atrial fibrillation (AF) commonly co‐exists with systolic heart failure (SHF) and its presence is associated with a worse prognosis. Despite this, a rhythm control approach using antiarrhythmic drugs (AADs) to reduce AF burden has demonstrated no prognostic benefit. Catheter ablation (AFA) is more effective than AADs at reducing AF burden. We performed a meta‐analysis to evaluate the impact of AFA on outcomes in SHF. Electronic databases were systematically searched. We included only randomized controlled trials that examined the impact of AFA on clinical outcomes in patients with SHF (LVEF
ISSN:1880-4276
1883-2148
DOI:10.1002/joa3.12115